Dingdang Health (09886) announced on September 21 that it spent roughly HK$197,600 to repurchase 241,500 of its shares, with the buyback price ranging from HK$0.795 to HK$0.84 per share.
The repurchase reflects the company's ongoing capital management strategy, aiming to enhance shareholder value through the buyback of its listed securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments